Skip to main content alibris logo

DNA Topoisomerases in Cancer Therapy: Present and Future

by

Write The First Customer Review
DNA Topoisomerases in Cancer Therapy: Present and Future - Andoh, Toshiwo (Editor)
Filter Results
Item Condition
Seller Rating
Other Options
Change Currency

In the mid 80's type I and II enzymes were found to be the intracellular targets of a number of efficacious anticancer drugs such as doxorubicin, mitoxantrone, etoposide and camptothecin as a result of a continued efforts of many investigators, especially Leroy Liu and his collaborators at Johns Hopkins University. Readers will find a series of chapters written by researchers actively engaged in the expanding field of topoisomerase and their inhibitors. The series of chapters cover review articles on pharmacology and the ...

loading
DNA Topoisomerases in Cancer Therapy: Present and Future 2012, Springer, New York, NY

ISBN-13: 9781461349419

Trade paperback

DNA Topoisomerases in Cancer Therapy: Present and Future 2003, Springer, New York, NY

ISBN-13: 9780306477447

2003 edition

Hardcover